Pitt Street Research | Stock research

Exopharm

Exopharm (ASX:EX1) is a Melbourne-based clinical-stage company developing exosome-based medicines. With its foundation LEAP technology, Exopharm arguably has the world’s best tools for manufacturing exosomes. The company has pivoted into drug delivery with new technologies for the creation of ‘engineered EVs’ (EEVs) that would allow exquisite targeting of therapeutic agents.

Exopharm Limited (ASX:EX1)

Exopharm is a Melbourne-based clinical-stage company developing exosome-based medicines. With its foundation LEAP technology, Exopharm arguably has the world’s best tools for manufacturing exosomes. The company has pivoted into drug delivery with new technologies for the creation of ‘engineered EVs’ (EEVs) that would allow exquisite targeting of therapeutic agents.